Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Ligeti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Protein and Peptide Letters|July 17, 2013
Biomedical hypothesis generation by text mining and gene prioritizationIngrid Petric, Balazs Ligeti, Balazs Gyorffy, et al.
Current Pharmaceutical Design|October 25, 2016
Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer TreatmentBalazs Ligeti, Otilia Menyhart, Ingrid Petric, et al.
Frontiers in Microbiology|February 28, 2019
Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in <i>Klebsiella pneumoniae</i> ST11 High-Risk Clone and Recently Emerging ST307 CloneJudit Domokos, Ivelina Damjanova, Katalin Kristof, et al.
Journal of Translational Medicine|November 20, 2024
Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancerDavid Dora, Peter Kiraly, Csenge Somodi, et al.
Journal of Medical Microbiology|January 23, 2019
Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 cloneBela Kocsis, Akos Toth, Daniel Gulyas, et al.
Medicina (Kaunas, Lithuania)|March 6, 2021
Association between Gut Microbial Diversity and Carotid Intima-Media ThicknessHelga Szabo, Anita Hernyes, Marton Piroska, et al.
Oncoimmunology|May 17, 2023
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 statusDavid Dora, Balazs Ligeti, Tamas Kovacs, et al.
Experimental Gerontology|December 12, 2018
Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiomeDora Abraham, Janos Feher, Gian Luca Scuderi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Protein and Peptide Letters|July 17, 2013
Biomedical hypothesis generation by text mining and gene prioritizationIngrid Petric, Balazs Ligeti, Balazs Gyorffy, et al.
Current Pharmaceutical Design|October 25, 2016
Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer TreatmentBalazs Ligeti, Otilia Menyhart, Ingrid Petric, et al.
Frontiers in Microbiology|February 28, 2019
Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in <i>Klebsiella pneumoniae</i> ST11 High-Risk Clone and Recently Emerging ST307 CloneJudit Domokos, Ivelina Damjanova, Katalin Kristof, et al.
Journal of Translational Medicine|November 20, 2024
Gut metatranscriptomics based de novo assembly reveals microbial signatures predicting immunotherapy outcomes in non-small cell lung cancerDavid Dora, Peter Kiraly, Csenge Somodi, et al.
Journal of Medical Microbiology|January 23, 2019
Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 cloneBela Kocsis, Akos Toth, Daniel Gulyas, et al.
Medicina (Kaunas, Lithuania)|March 6, 2021
Association between Gut Microbial Diversity and Carotid Intima-Media ThicknessHelga Szabo, Anita Hernyes, Marton Piroska, et al.
Oncoimmunology|May 17, 2023
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 statusDavid Dora, Balazs Ligeti, Tamas Kovacs, et al.
Experimental Gerontology|December 12, 2018
Exercise and probiotics attenuate the development of Alzheimer's disease in transgenic mice: Role of microbiomeDora Abraham, Janos Feher, Gian Luca Scuderi, et al.
Pageof 1